赵媛媛 - 中山大学 - 肿瘤防治中心

个人简介

2012年获得肿瘤学博士学位后留院工作。 2012/8 - 2013/12，中山大学，肿瘤防治中心，医师 2014/1 - 2016/12, 中山大学，肿瘤防治中心，主治医师 2017/1 – 至今，中山大学，肿瘤防治中心，副主任医师

研究领域

肿瘤内科治疗（化学治疗、靶向治疗）的临床工作及抗癌药物研究。主要专业方向是胸部肿瘤及鼻咽癌的内科治疗及研究

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1)Zhao YY, Li S, Zhang Y, Zhao HY, Liao H, Guo Y, Shi YX, Jiang W, Xue C, Zhang L.The relationship between drug exposure and clinical outcomes of non-small cell lung cancer patients treated with gefitinib. Med Oncol. 2011 Sep;28(3):697-702. 2)Zhao YY, Xue C, Hou X, Liao H, Li S, Zhao HY, Huang Y, Chen LK, Xu F, Liu JL, Zhang L Changes of bone resorption marker (NTX) in chemotherapy plus zoledronic acid versus chemotherapy alone for nasopharyngeal cancer patients with bone metastases. Eur J Cancer. 2011 Apr;47(6):848-53. 3)Zhao YY, Xue C, Jiang W , Zhao HY, Huang Y, Feenstra K, Resau JH, Qian CN, Zhang L. Predictive Value of Intratumoral Microvascular Density in Patients with Advanced Non-small Cell Lung Cancer Receiving Chemotherapy Plus Bevacizumab. J Thorac oncol. 2012 Jan;7(1):71-5. 4)Zhai L, Zhao Y, Ye S, Huang H, Tian Y, Wu Q, Lin H, Lin T. Expression of PIK3CA and FOXP1 in gastric and intestinal non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue type. Tumour Biol. 2011 Oct;32(5):913-20. 5)Zhai L, Zhao Y, Lin L, Tian Y, Chen X, Huang H, Lin T. Non-Hodgkin's Lymphoma Involving the Ileocecal Region: A Single-institution Analysis of 46 Cases in a Chinese Population. J Clin Gastroenterol. 2012 Jul;46(6):509-14. 6)Hongyun Zhao, Yuanyuan Zhao, Ying Guo, Yan Huang, Suxia Lin, Cong Xue, Fei Xu, Yang Zhang, Liping Zhao, Zhihuang Hu, Li Zhang.: Clinical significance of the thymidylate synthase, dihydropyrimidine dehydrogenase, and thymidine phosphorylase mRNA expressions in hepatocellular carcinoma patients receiving 5-fluorouracil-based transarterial chemoembolization treatment. Onco Targets and Therapy2013; Vol 6:811-818 (SCI=2.073). 7)Jian-Wei Zhang, Yuan-Yuan Zhao, Ying Guo, Cong Xue, Zhi-Huang Hu, Yan Huang, Hong-Yun Zhao, Jing Zhang, Xuan Wu, Wen-Feng Fang, Yu-Xiang Ma, Li Zhang.: The impact of both platinum-based chemotherapy and EGFR-TKIs on overall survival of advanced non--small cell lung cancer. Chin J Cancer. 2014 Feb 5; 33(2):105-14 8)Wu JX, Zhao YY, Wu X, An HX. Clinicopathological and Prognostic Significance of CD24 Overexpression in Patients with Gastric Cancer: A Meta-Analysis. PLoS One. 2014 Dec 12;9(12):e114746. 9)Zhao YY, Tian Y, Zhang J, Xu F, Yang YP, Huang Y, Zhao HY, Zhang JW, Xue C, Lam MH, Yan L, Hu ZH, Dinglin XX, Zhang L. Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo. Drug Des Devel Ther. 2014 Oct 10;8:1827-37 10)Xin S, Zhao Y, Wang X, Huang Y, Zhang J, Guo Y, Li J, Li H, Ma Y, Chen L, Hu Z, Huang M, Zhang L. The Dissociation of Gefitinib Trough Concentration and Clinical Outcome in NSCLC Patients with EGFR Sensitive Mutations. Sci Rep. 2015 Jul 31; 5:12675 11)Zhao Y, Zhang J, Tian Y, Xue C, Hu Z, Zhang L. Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma. Drug Des Devel Ther. 2015 Aug 26; 9:4897-907 12)Zhai L, Zhao Y, Peng S, Zhu K, Yu R, Chen H, Lin T, Lin L. Detection of the value of consecutive serum total light chain (sTLC) in patients diagnosed with diffuse large B cell lymphoma. Ann Hematol. 2016 Dec;95(12):1999-2007 13)Zhao YY, Liu L, Zhou T, Zhou NN, Yang YP, Hou X, Li Y, Zhao HY, Huang Y, Zhang L. A retrospective analysis of the clinicopathological and molecular characteristics of pulmonary blastoma. Onco Targets Ther. 2016 Nov 8; 9:6915-6920